Literature DB >> 20852697

Physostigmine as an antidote.

M Stilson1, K Kelly, J Suchard.   

Abstract

Entities:  

Year:  2001        PMID： 20852697      PMCID： PMC2906923     

Source DB:  PubMed          Journal:  Cal J Emerg Med        ISSN： 1948-3384


× No keyword cloud information.
  6 in total

1.  Response: physostigmine may not be the only option for treating anticholinergic syndrome.

Authors:  Thomas Pluim
Journal:  J Med Toxicol       Date:  2015-03

2.  Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.

Authors:  Michelle A Phillips; Nicole M Acquisto; Rachel M Gorodetsky; Timothy J Wiegand
Journal:  J Med Toxicol       Date:  2014-06

3.  Massive atropine eye drop ingestion treated with high-dose physostigmine to avoid intubation.

Authors:  Samuel J Stellpflug; Jon B Cole; Brian A Isaacson; Christian P Lintner; Elisabeth F Bilden
Journal:  West J Emerg Med       Date:  2012-02

4.  Therapeutic effects of physostigmine during systemic inflammation.

Authors:  Katharina Effenberger-Neidnicht; Johannes Jägers; Rabea Verhaegh; Michael Kirsch
Journal:  J Inflamm Res       Date:  2018-12-07

5.  Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer's Disease and Other Neurological Disorders.

Authors:  Muhammad Ayaz; Farhat Ullah; Abdul Sadiq; Myeong Ok Kim; Tahir Ali
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

6.  Atropine toxicity caused by erroneous intranasal administration in a pediatric patient: case report.

Authors:  Lama S Alaula; Mohammad Al-Kadi; Abdullah Almajed; Riyadh Alhedaithy
Journal:  Ann Saudi Med       Date:  2019-08-05       Impact factor: 1.526
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.